Alimera Sciences Inc. (NASDAQ: ALIM) is 28.01% higher on its value in year-to-date trading and has touched a low of $2.61 and a high of $5.65 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALIM stock was last observed hovering at around $5.54 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $5.53, the stock is -0.83% and 1.17% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -0.18% at the moment leaves the stock 35.91% off its SMA200. ALIM registered 58.91% gain for a year compared to 6-month gain of 49.06%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.54% loss in the last 1 month and extending the period to 3 months gives it a 81.31%, and is -1.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.61% over the week and 0.49% over the month.
Alimera Sciences Inc. (ALIM) has around 159 employees, a market worth around $300.72M and $99.68M in sales. Fwd P/E is 29.11. Profit margin for the company is -15.32%. Distance from 52-week low is 112.18% and -2.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.83%).
The EPS is expected to grow by 83.97% this year.
Alimera Sciences Inc. (ALIM) Top Institutional Holders
68.0 institutions hold shares in Alimera Sciences Inc. (ALIM), with institutional investors hold 91.42% of the company’s shares. The shares outstanding are 52.35M, and float is at 50.86M with Short Float at 1.32%. Institutions hold 86.53% of the Float.
The top institutional shareholder in the company is CALIGAN PARTNERS LP with over 16.84 million shares valued at $93.6 million. The investor’s holdings represent 30.9563% of the ALIM Shares outstanding. As of 2024-06-30, the second largest holder is VELAN CAPITAL INVESTMENT MANAGEMENT LP with 13.61 million shares valued at $$75.66 million to account for 25.0232 of the shares outstanding. The other top investors are STONEPINE CAPITAL MANAGEMENT, LLC which holds 3.51 million shares representing 6.4575% and valued at over $19.53 million, while BOOTHBAY FUND MANAGEMENT, LLC holds 5.8818 of the shares totaling 3.2 million with a market value of $17.78 million.
Alimera Sciences Inc. (ALIM) Insider Activity
The most recent transaction is an insider purchase by Caligan Partners LP,the company’s10% Owner. SEC filings show that Caligan Partners LP bought 579,000 shares of the company’s common stock on Sep 14 ’23 at a price of $3.39 per share for a total of $1.96 million. Following the purchase, the insider now owns 16.84 million shares.
Alimera Sciences Inc. disclosed in a document filed with the SEC on Sep 14 ’23 that Caligan Partners LP (10% Owner) sold a total of 579,000 shares of the company’s common stock. The trade occurred on Sep 14 ’23 and was made at $3.39 per share for $1.96 million. Following the transaction, the insider now directly holds 16.26 million shares of the ALIM stock.
